Sector

Healthcare

One of the most prominent practices in Europe, on a growing resilient sector, underpinned by constant innovation in biotech and medtech, and long-term demand for healthcare services.

Bryan, Garnier & Co's insights and news

Read the latest news, reports and newsletters from Europe’s Growth Investment Bank to find out more about current trends impacting investment banking activity and company performance.

Healthcare transactions

Bryan, Garnier & Co offers a complete range of investment banking services, from growth financing to mergers and acquisitions.

Bryan, Garnier & Co advised LIFCO on its acquisition of Physics Forceps dental product assets from GoldenDent

Goldendent_tombstone

Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance

Beringer tombstone

Bryan, Garnier & Co acts as Joint Bookrunner to Genfit on its $155.4 million Nasdaq Initial Public Offering

Genfit tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Activa Capital and Turenne Capital on the acquisition of Medisys

Activa_Tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to HighLife on its €32 million Series B Fundraising

Highlife tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to life insurance platform Quality Insurance Services on its sale to CNP Assurances

QIS tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for MedinCell’s €30 million Euronext Paris IPO

MedinCell tombstone

Bryan, Garnier & Co acts as Sole Financial Advisor to Montagu Private Equity on the acquisition of Maincare Solutions

Maincare Solutions tombstone

Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising

Blueberry Therapeutics tombstone

Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq

Materialise tombstone

Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader

TxCell tombstone

Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement

ASIT biotech tombstone

Private Placement OncoImmunity AS

Oncolmmunity_tombstone_jul18

Bryan, Garnier & Co acts as Co-manager on Canopy Growth’s benchmark CAD600 million Convertible Bond New Issue

Canopy_2018_tombstone

Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for Voluntis’ IPO, the first ever listing of a digital therapeutics company raising EUR30.1 million

Voluntis tombstone

Bryan, Garnier & Co acts as Lead Manager on Medigene’s EUR48.3 million offering

Medigene tombstone

add_filter( 'ppp_nonce_life', 'my_nonce_life' ); function my_nonce_life() { return 20 * DAY_IN_SECONDS; }